Stay updated on Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying that “Super Intelligence” will be used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T13:30:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:06:03.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T13:52:51.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page, replacing the study record content. This indicates restricted access or a site error rather than a substantive update.
    Difference
    20%
    Check dated 2026-09-20T19:39:42.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    No additions or deletions were found in the changes data, so the page content appears unchanged between versions.
    Difference
    0.1%
    Check dated 2026-09-13T17:31:09.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    No textual additions or deletions were provided; the page content remains as currently listed based on the input data.
    Difference
    0.1%
    Check dated 2026-09-06T12:15:28.000Z thumbnail image

Stay in the know with updates to Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of CAN04 and Pembrolizumab in Solid Tumors Clinical Trial page.